Health Care & Life Sciences » Pharmaceuticals | Pacira Pharmaceuticals Inc.

Pacira Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Pacira Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
HBM BioVentures Ltd.
1,100,000
2.69%
0
3.52%
12/31/2017
ClearBridge Small Cap Growth Fund
981,276
2.4%
0
1.27%
01/31/2018
Vanguard Total Stock Market Index Fund
976,014
2.38%
1,058
0.01%
07/31/2018
Vanguard Small Cap Index Fund
974,287
2.38%
14,637
0.05%
07/31/2018
iShares Russell 2000 ETF
839,654
2.04%
-447
0.08%
09/06/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
789,630
1.93%
-60,420
0.01%
03/31/2018
T Rowe Price Small Cap Stock Fund
732,400
1.79%
-54,500
0.33%
06/30/2018
Vanguard Explorer Fund
566,158
1.38%
138,284
0.16%
06/30/2018
Vanguard Small Cap Growth Index Fund
556,862
1.36%
9,611
0.1%
07/31/2018
Vanguard Extended Market Index Fund
539,805
1.32%
4,300
0.04%
07/31/2018

About Pacira Pharmaceuticals

View Profile
Address
5 Sylvan Way
Parsippany New Jersey 07054
United States
Employees -
Website http://www.pacira.com
Updated 07/08/2019
Pacira Pharmaceuticals, Inc. is a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. The company was founded in December 2006 and is headquartered in Parsippany, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.